The U.S. Food and Drug Administration approved a new non-opioid pain medication developed by the Massachusetts-based company ...
A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will ...
The Food and Drug Administration announced the approval of a new non-opioid pain medication this week, marking the first time ...
The drug, shown to be almost as effective as opioids for short-term pain, is the first fundamentally new kind of painkiller ...
The FDA removed previously issued draft guidance on diversity in clinical trials from its website without public notice or ...
Washington — Federal officials on Thursday approved a new type of pain pill designed to eliminate the risks of addiction and ...
The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class ...
The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under the brand name Journavx.
The greenlight for Journavx (suzetrigine), which comes on the heels of a $7.4 billion opioid settlement, could spark momentum ...
Despite high demand for an option like Journavx, doctors fear the drug’s price could be a hangup for insurers and limit ...
When politicians subordinate scientific institutions to electoral interests, they undermine immediate public health efforts ...
The drug offers a non-addictive alternative to opioids, marking 'an important public health milestone in acute pain ...